Are you living with Multiple Sclerosis (MS)?
We are seeking participants with Multiple Sclerosis (MS) to take part in clinical research.
The FREVIVA trial is designed for men and women between the ages of 18 and 60 diagnosed with secondary progressive multiple sclerosis (SPMS).
The FREXALT trial is designed for men and women between the ages of 18 and 55 diagnosed with relapsing multiple sclerosis (RMS).
Get in touch with our friendly team and discover how you can take part: